Surgery for chronic pancreatitis
Executive Summary
Chronic pancreatitis (CP) is a progressive inflammatory disorder characterized by fibrotic replacement of the pancreatic parenchyma, leading to severe abdominal pain and endocrine/exocrine failure. While initial management focuses on risk factor modification and medical therapy, 40% to 75% of patients eventually require surgical intervention, primarily for debilitating, refractory pain.
Recent evidence, including a 2024 meta-analysis and the ESCAPE trial, indicates that early surgical intervention provides superior long-term pain relief and higher patient satisfaction compared to an endoscopy-first approach. Delaying surgery through prolonged endoscopic interventions or daily opioid use is associated with poorer clinical outcomes.
Surgical planning is fundamentally driven by pancreatic ductal anatomy and the location of diseased tissue:
Dilated Ducts (≥6–7 mm): Managed via drainage procedures (e.g., Lateral Pancreaticojejunostomy or the Frey procedure).
Nondilated Ducts (<6–7 mm): Managed via resection (e.g., Pancreaticoduodenectomy, Distal Pancreatectomy, or Total Pancreatectomy).
Comparative Efficacy: Surgery vs. Endoscopy
The clinical consensus regarding the timing of surgery is shifting toward earlier intervention. Meta-analyses of randomized trials suggest surgery results in lower Izbicki pain scores and higher rates of complete pain relief compared to endoscopic retrograde cholangiopancreatography (ERCP).
Key Clinical Trial Findings
Surgical Decision-Making for Intractable Pain
The primary determinants for operative selection are ductal anatomy and gland morphology. The following decision-making pathway is supported by 2020 international consensus guidelines.
1. Dilated Pancreatic Duct (≥6–7 mm)
Patients with dilated ducts are assumed to have obstructive pancreatopathy, making them candidates for drainage procedures that preserve pancreatic parenchyma and function.
Lateral Pancreaticojejunostomy (LPJ/Puestow Procedure):
Technique: The pancreatic duct is opened longitudinally and anastomosed to a Roux-en-Y jejunal limb.
Outcomes: Pain relief rates range from 48% to 91%. Complications (20%) include hemorrhage and anastomotic leaks.
Benefits: Preservation or potential enhancement of endocrine and exocrine function.
Frey Procedure (LPJ with Local Head Resection):
Technique: Combines LPJ with "coring out" fibrotic tissue in the pancreatic head and uncinate process.
Outcomes: Reports show 62% to 91% pain relief. It addresses fibrotic parenchyma and neural damage that a simple drainage might miss.
2. Nondilated Pancreatic Duct (<6–7 mm)
In cases where the duct is small, drainage is ineffective; therefore, resection of the fibrotic parenchyma is required.
Head-Dominant Disease:
Classic Pancreaticoduodenectomy (PD/Whipple): Indicated for inflammatory masses in the head or biliary/duodenal obstruction. Pain relief is achieved in 70% to 89% of cases.
Pylorus-Preserving PD (PPPD): Aimed at maintaining gastric emptying; offers similar long-term outcomes to the classic Whipple.
Duodenum-Preserving Pancreatic Head Resection (DPPHR/Beger): A subtotal resection of the head that preserves a rim of parenchyma near the duodenum. It offers shorter operative times and hospital stays compared to PD, though PD may be more definitive with fewer readmissions.
Tail-Dominant Disease:
Distal Pancreatectomy (DP): Effective when disease is localized to the left of the pancreas. Due to inflammatory changes or splenic vein thrombosis, it is often performed with a splenectomy. Pain relief rates range from 57% to 84%, but the risk of postoperative diabetes is significant (8% to 45%).
Diffuse Parenchymal Involvement:
Total Pancreatectomy (TP): Used as a last resort or for genetic/small duct pancreatitis. While pain relief is high (72%–100%), it results in "brittle" Type 3c diabetes and loss of glucose homeostasis.
TP with Islet Autotransplantation (TPIAT): The preferred approach for diffuse disease to mitigate diabetes. Patients achieve 72% to 86% pain relief, with 10% to 40% reaching full insulin independence. Outcomes are particularly durable in pediatric patients and those with genetic pancreatitis.
Management of Non-Pain Complications
Chronic pancreatitis can lead to various structural complications requiring specific surgical interventions beyond pain management.
Role of Minimally Invasive Surgery
Laparoscopic and robotic techniques have been applied to LPJ, distal pancreatectomy, and pancreaticoduodenectomy.
Benefits: Laparoscopic distal pancreatectomy is associated with less blood loss and shorter hospital stays.
Limitations: Wide application is restricted by the distorted anatomy, fibrosis, and loss of tissue planes intrinsic to chronic pancreatitis, which increase technical difficulty.
